SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-052714
Filing Date
2019-10-07
Accepted
2019-10-07 18:13:33
Documents
2
Period of Report
2019-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3142
2 POA DOCUMENT poa.txt EX-24.3_875563 3925
  Complete submission text file 0001209191-19-052714.txt   8477
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1751 RIVER RUN SUITE 400 FT WORTH TX 76107
Business Address
Fletcher Aaron G.L. (Reporting) CIK: 0001789490 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38327 | Film No.: 191141607